Literature DB >> 31140224

The Effect of Pulmonary Rehabilitation on Non-chronic Obstructive Pulmonary Disease Patients.

Ariel Rokach1,2, Ayal Romem1,2, Nissim Arish1,2, Hava Azulai1,2, Chen Chen1,2, Milka Bertisch3,2, Gabriel Izbicki1,2.   

Abstract

BACKGROUND: Pulmonary rehabilitation has shown significant benefit for patients with chronic obstructive pulmonary disease (COPD). The effect on non-COPD pulmonary patients is less well established.
OBJECTIVES: To determine whether pulmonary rehabilitation is also beneficial for non-COPD pulmonary patients.
METHODS: Clinical and demographic data on non-COPD pulmonary patients who participated in our institutional pulmonary rehabilitation program between January 2009 and December 2016 were collected. Participants engaged in a 60-minute, twice-weekly, ambulatory hospital-based program lasting 12 to 24 sessions. Sessions included both endurance and muscle training as well as healthy lifestyle educational activities. The six-minute walk test (6MWT) and the St. George's Respiratory Questionnaire (SGRQ) were conducted before and after the rehabilitation program.
RESULTS: We recruited 214 non-COPD patients, of whom 153 completed at least 12 sessions. Of these, 59 presented with interstitial lung disease (ILD), 18 with non-ILD restrictive lung defects, 25 with asthma, 30 with lung cancer, and 21 with other conditions (e.g., pulmonary hypertension, bronchiectasis) The groups demonstrated significant improvement in 6MWT and in SGRQ scores. Non-COPD patients gained a 61.9 meter (19%) improvement in the 6MWT (P < 0.0001) and 8.3 point reduction in their SGRQ score (P < 0.0001).
CONCLUSIONS: Pulmonary rehabilitation is effective in non-COPD pulmonary patients. As such, it should be an integral part of the treatment armament provided to the vast majority of those suffering from chronic respiratory disease.

Entities:  

Mesh:

Year:  2019        PMID: 31140224

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  3 in total

1.  Current status and trends of pulmonary rehabilitation in South Korea: National level data analysis using Health Insurance Review and Assessment Service (HIRA) database from 2016 to 2018.

Authors:  Hyo-Jung Kim; Hee-Eun Choi; Hang-Jea Jang; Hyun-Kuk Kim; Jin-Han Park; Jae-Ha Lee; Tae-Hoon Kim
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

2.  Patient-reported outcome measures in systemic sclerosis-related interstitial lung disease for clinical practice and clinical trials.

Authors:  Lesley Ann Saketkoo; Mary Beth Scholand; Matthew R Lammi; Anne-Marie Russell
Journal:  J Scleroderma Relat Disord       Date:  2020-03-05

Review 3.  Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020).

Authors:  Chunxue Bai; Sanjay H Chotirmall; Jordi Rello; George A Alba; Leo C Ginns; Jerry A Krishnan; Robert Rogers; Elisabeth Bendstrup; Pierre-Regis Burgel; James D Chalmers; Abigail Chua; Kristina A Crothers; Abhijit Duggal; Yeon Wook Kim; John G Laffey; Carlos M Luna; Michael S Niederman; Ganesh Raghu; Julio A Ramirez; Jordi Riera; Oriol Roca; Maximiliano Tamae-Kakazu; Antoni Torres; Richard R Watkins; Miriam Barrecheguren; Mirko Belliato; Hassan A Chami; Rongchang Chen; Gustavo A Cortes-Puentes; Charles Delacruz; Margaret M Hayes; Leo M A Heunks; Steven R Holets; Catherine L Hough; Sugeet Jagpal; Kyeongman Jeon; Takeshi Johkoh; May M Lee; Janice Liebler; Gerry N McElvaney; Ari Moskowitz; Richard A Oeckler; Iñigo Ojanguren; Anthony O'Regan; Mathias W Pletz; Chin Kook Rhee; Marcus J Schultz; Enrico Storti; Charlie Strange; Carey C Thomson; Francesca J Torriani; Xun Wang; Wim Wuyts; Tao Xu; Dawei Yang; Ziqiang Zhang; Kevin C Wilson
Journal:  Eur Respir Rev       Date:  2020-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.